skip to Main Content

SPR Therapeutics® Secures $25 Million in Series C Financing

  • September 12, 2017
  • News

SPR Therapeutics® Secures $25 Million in Series C Financing Funding will support commercialization of SPRINT® PNS System, a non-opioid neurostimulation pain-relief therapy for chronic and acute pain CLEVELAND, Sept. 12, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., (SPR) a private…

Read More
Back To Top